KIF23 Promotes Gastric Cancer by Stimulating Cell Proliferation

Abstract EN

Gastric cancer (GC) is one of the most aggressive malignant tumors with low early diagnosis and high metastasis.

Despite progress in treatment, to combat this disease, a better understanding of the underlying mechanisms and novel therapeutic targets is needed.

KIF23, which belongs to the KIF family, plays a vital role in various cell processes, such as cytoplasm separation and axon elongation.

Nowadays, KIF23 has been found to be highly expressed in multiple tumor tissues and cells, suggesting a potential link between KIF23 and tumorigenesis.

Herein, we reported that KIF23 expression was correlated with poor prognosis of gastric cancer and found an association between KIF23 and pTNM stage.

An in vitro assay proved that the proliferation of gastric cancer cells was significantly inhibited, which is caused by KIF23 depletion.

Additionally, knockdown of KIF23 resulted in a marked inhibition of cell proliferation of gastric cancer in mice, with significant downregulation of Ki67 and PCNA expression.

In conclusion, these data indicate that KIF23 is a potential therapeutic target for gastric cancer treatment.